XML 20 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Consolidated net income (loss) $ 29,739 $ (4,183)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 33,645 35,664
Gain on legal settlement (21,474)  
Amortization of intangibles, contract costs, deferred financing costs and bond premium 5,013 5,460
Provision for doubtful accounts 406 73
Provision for inventory obsolescence 319 122
Non-cash share-based compensation expense 1,507 1,551
Gain on sales and disposals of equipment (1,050) (1,046)
Deferred income taxes 164 204
Interest on note receivable (21) (11)
Changes in operating assets and liabilities:    
Accounts receivable (5,173) 158
Inventories (554) 495
Other operating assets 38 (414)
Accounts payable 209 (3,639)
Other operating liabilities 3,057 (3,381)
Net cash provided by operating activities 45,825 31,053
Cash flows from investing activities:    
Medical equipment purchases (23,273) (24,296)
Property and office equipment purchases (4,316) (3,309)
Proceeds from disposition of property and equipment 1,813 2,091
Issuance of note receivable from officer (581) (936)
Acquisitions and refund of escrow   (1,923)
Net cash used in investing activities (26,357) (28,373)
Cash flows from financing activities:    
Proceeds under senior secured credit facility 104,448 83,200
Payments under senior secured credit facility (113,598) (79,692)
Payments of principal under capital lease obligations (3,072) (3,419)
Holdback payment related to acquisition (624)  
Distributions to noncontrolling interests (213) (133)
Proceed from exercise of parent company stock options 285 29
Contribution from Parent   1,900
Shares forfeited for taxes 1,149  
Change in book overdrafts (5,367) (4,565)
Net cash used in financing activities (19,290) (2,680)
Net change in cash and cash equivalents 178 0
Cash and cash equivalents at the beginning of period
Cash and cash equivalents at the end of period 178  
Supplemental cash flow information:    
Interest paid 26,332 26,345
Income taxes paid 676 533
Non-cash activities:    
Medical equipment purchases included in accounts payable (at end of period) 3,920 4,493
Capital lease additions $ 1,858 $ 3,179